Gabapentin and Urocit-k drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Gabapentin (gabapentin) and Urocit-k (potassium citrate). Common drug interactions include emotional distress among females and insomnia among males.

The phase IV clinical study analyzes what interactions people have when they take Gabapentin and Urocit-k. It is created by eHealthMe based on reports of 64 people who take the same drugs from the FDA, and is updated regularly.

What is Gabapentin?

Gabapentin has active ingredients of gabapentin. It is often used in neuralgia. eHealthMe is studying from 322,983 Gabapentin users. Check the latest studies of Gabapentin.

What is Urocit-k?

Urocit-k has active ingredients of potassium citrate. It is often used in kidney stones. eHealthMe is studying from 708 Urocit-k users. Check the latest studies of Urocit-k.



On Jul, 11, 2026

64 people who take Gabapentin and Urocit-k together, and have interactions are studied.

Gabapentin and Urocit-k drug interactions.

What are the common drug interactions of Gabapentin and Urocit-K, by gender? *:

female:

  1. Emotional distress
  2. Pyuria (a condition of urine containing pus)
  3. Facial bones fracture (bone fracture of face)
  4. Fall
  5. Femur fracture
  6. Neck pain
  7. Bone disorder
  8. Cardiac failure congestive
  9. Chondromalacia (anterior knee pain due to irritation of the cartilage on the under surface of the kneecap)
  10. Deformity (disfigurement)

male:

  1. Insomnia (sleeplessness)
  2. Bursitis (inflammation of a bursa, typically one in the knee, elbow, or shoulder)
  3. Cardiac disorder
  4. Chest discomfort
  5. Chronic kidney disease
  6. Liver disorder (liver diseases)
  7. Renal disorder (kidney disease)

What are the common drug interactions of Gabapentin and Urocit-K, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

  1. Insomnia (sleeplessness)
  2. Pharyngitis (inflammation of the pharynx, causing a sore throat)
  3. Steatorrhoea (presence of excess fat in faeces)

40-49:

  1. Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  2. Anxiety
  3. Arthralgia (joint pain)
  4. Bone density decreased
  5. Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
  6. Chronic kidney disease
  7. Decreased activity
  8. Dental caries
  9. Depression
  10. Diarrhoea

50-59:

  1. Dry mouth
  2. Emotional distress
  3. Eye infection
  4. Eye pain
  5. Facial bones fracture (bone fracture of face)
  6. Fall
  7. Femur fracture
  8. Glossitis (infection of tongue with soreness)
  9. Groin pain
  10. Haemolytic anaemia (anaemia due to haemolysis)

60+:

  1. Incontinence (lack of moderation or self-control)
  2. Vomiting
  3. Bone pain
  4. Breast cancer recurrent
  5. Bruxism (habitual grinding of the teeth, typically during sleep)
  6. Bursitis (inflammation of a bursa, typically one in the knee, elbow, or shoulder)
  7. Cardiac failure congestive
  8. Carditis (infection of heart and surrounding)
  9. Cellulitis (infection under the skin)
  10. Chest pain

What are the existing conditions these people have? *

  1. Multiple Myeloma (cancer of the plasma cells): 8 people, 12.50%
  2. Breast Cancer: 8 people, 12.50%
  3. Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 6 people, 9.38%
  4. Osteoporosis (bones weak and more likely to break): 5 people, 7.81%
  5. Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 5 people, 7.81%
  6. High Blood Pressure: 5 people, 7.81%
  7. Cataplexy (loss of muscle tone accompanied by full conscious awareness): 5 people, 7.81%
  8. Metastases To Bone (cancer spreads to bone): 4 people, 6.25%
  9. High Blood Cholesterol: 4 people, 6.25%
  10. Diabetes: 4 people, 6.25%

* Approximation only. Some reports may have incomplete information.

Do you take Gabapentin and Urocit-k?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Gabapentin and Urocit-k:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Gabapentin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Urocit-k:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Gabapentin and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Urocit-k and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on gabapentin and potassium citrate (the active ingredients of Gabapentin and Urocit-k, respectively), and Gabapentin and Urocit-k (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: